KAITLYN PETRAKIS: Open Payments
NPI 1255839593 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 67 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $342 |
| Bioventus LLC | 4 | $222 |
| Novo Nordisk Inc | 10 | $174 |
| GlaxoSmithKline, LLC. | 8 | $163 |
| Phathom Pharmaceuticals, Inc. | 2 | $151 |
| Exact Sciences Corporation | 3 | $132 |
| Lilly USA, LLC | 6 | $117 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| PFIZER INC. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
Products named: XCELL, VOQUEZNA, TRELEGY ELLIPTA, BREZTRI, MOUNJARO, FARXIGA, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
